HEADER RECEPTOR 29-JUL-07 2V7C TITLE CRYSTAL STRUCTURE OF REV-ERB BETA COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORPHAN NUCLEAR RECEPTOR NR1D2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN, RESIDUES 386-579; COMPND 5 SYNONYM: REV-ERB-BETA, EAR-1R, ORPHAN NUCLEAR HORMONE COMPND 6 RECEPTOR BD73; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS DNA-BINDING, TRANSCRIPTION, METAL-BINDING, ZINC, NUCLEUS, KEYWDS 2 RECEPTOR, REPRESSOR, ZINC-FINGER, CONSTITUTIVE REPRESSION, KEYWDS 3 TRANSCRIPTION REGULATION, ORPHAN RECEPTOR, A-HELICAL KEYWDS 4 SANDWICH EXPDTA X-RAY DIFFRACTION AUTHOR E.-J.WOO,D.G.JEONG,M.-Y.LIM,S.J.KIM,S.E.RYU REVDAT 2 24-FEB-09 2V7C 1 VERSN REVDAT 1 23-OCT-07 2V7C 0 JRNL AUTH E.-J.WOO,D.G.JEONG,M.-Y.LIM,S.J.KIM,K.-J.KIM, JRNL AUTH 2 S.-M.YOON,B.-C.PARK,S.E.RYU JRNL TITL STRUCTURAL INSIGHT INTO THE CONSTITUTIVE JRNL TITL 2 REPRESSION FUNCTION OF THE NUCLEAR RECEPTOR JRNL TITL 3 REV-ERBBETA JRNL REF J.MOL.BIOL. V. 373 735 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17870090 JRNL DOI 10.1016/J.JMB.2007.08.037 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 213935.50 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 26828 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.9 REMARK 3 FREE R VALUE TEST SET COUNT : 1323 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.8 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3958 REMARK 3 BIN R VALUE (WORKING SET) : 0.276 REMARK 3 BIN FREE R VALUE : 0.346 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.6 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 234 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2586 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 104 REMARK 3 SOLVENT ATOMS : 59 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.5 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.7 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.45 REMARK 3 B22 (A**2) : 4.45 REMARK 3 B33 (A**2) : -8.89 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.35 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.2 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.6 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.85 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.350549 REMARK 3 BSOL : 46.0598 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DISORDERED REGION CHAIN A 471-480 REMARK 4 REMARK 4 2V7C COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JUL-07. REMARK 100 THE PDBE ID CODE IS EBI-33296. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 6C1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97935 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74212 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.90 REMARK 200 RESOLUTION RANGE LOW (A) : 50.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 8.4 REMARK 200 R MERGE (I) : 0.05 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.10 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.2 REMARK 200 R MERGE FOR SHELL (I) : 0.74 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% POLYETHYLENE GLYCOL 4000, REMARK 280 10% ISOPROPANOL, 100MM HEPES (PH 7.5) REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.78300 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 35.83850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 35.83850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.39150 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 35.83850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 35.83850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 109.17450 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 35.83850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 35.83850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.39150 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 35.83850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 35.83850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 109.17450 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 72.78300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 386 REMARK 465 SER A 387 REMARK 465 LYS A 388 REMARK 465 SER A 389 REMARK 465 PRO A 390 REMARK 465 TYR A 391 REMARK 465 VAL A 392 REMARK 465 ASP A 393 REMARK 465 PRO A 394 REMARK 465 HIS A 395 REMARK 465 LYS A 396 REMARK 465 SER A 397 REMARK 465 GLY A 398 REMARK 465 HIS A 399 REMARK 465 GLU A 400 REMARK 465 ILE A 401 REMARK 465 TRP A 402 REMARK 465 VAL A 471 REMARK 465 ASP A 472 REMARK 465 ASP A 473 REMARK 465 LEU A 474 REMARK 465 HIS A 475 REMARK 465 SER A 476 REMARK 465 MSE A 477 REMARK 465 GLY A 478 REMARK 465 ALA A 479 REMARK 465 HIS A 578 REMARK 465 PRO A 579 REMARK 465 MSE B 386 REMARK 465 SER B 387 REMARK 465 LYS B 388 REMARK 465 SER B 389 REMARK 465 PRO B 390 REMARK 465 TYR B 391 REMARK 465 VAL B 392 REMARK 465 ASP B 393 REMARK 465 PRO B 394 REMARK 465 HIS B 395 REMARK 465 LYS B 396 REMARK 465 LEU B 573 REMARK 465 ALA B 574 REMARK 465 PHE B 575 REMARK 465 LYS B 576 REMARK 465 VAL B 577 REMARK 465 HIS B 578 REMARK 465 PRO B 579 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 575 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 576 CG CD CE NZ REMARK 470 VAL A 577 CA C O CB CG1 CG2 REMARK 470 LEU B 572 CA C O CB CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 404 45.87 21.47 REMARK 500 PHE A 405 -30.24 168.75 REMARK 500 SER A 406 -75.88 -45.63 REMARK 500 ASP A 455 85.12 -152.37 REMARK 500 ASP A 515 125.46 -36.12 REMARK 500 GLU A 571 29.52 -72.95 REMARK 500 LEU A 572 -54.47 -152.46 REMARK 500 LEU A 573 39.52 -70.03 REMARK 500 PHE A 575 15.86 57.33 REMARK 500 THR B 410 -66.19 -18.08 REMARK 500 PRO B 411 32.71 -71.14 REMARK 500 HIS B 544 55.77 -146.48 REMARK 500 PRO B 545 -70.22 -19.20 REMARK 500 GLU B 547 48.29 -163.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE) REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2V0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF REV-ERB BETA DBREF 2V7C A 386 579 UNP Q14995 NR1D2_HUMAN 386 579 DBREF 2V7C B 386 579 UNP Q14995 NR1D2_HUMAN 386 579 SEQRES 1 A 194 MSE SER LYS SER PRO TYR VAL ASP PRO HIS LYS SER GLY SEQRES 2 A 194 HIS GLU ILE TRP GLU GLU PHE SER MSE SER PHE THR PRO SEQRES 3 A 194 ALA VAL LYS GLU VAL VAL GLU PHE ALA LYS ARG ILE PRO SEQRES 4 A 194 GLY PHE ARG ASP LEU SER GLN HIS ASP GLN VAL ASN LEU SEQRES 5 A 194 LEU LYS ALA GLY THR PHE GLU VAL LEU MSE VAL ARG PHE SEQRES 6 A 194 ALA SER LEU PHE ASP ALA LYS GLU ARG THR VAL THR PHE SEQRES 7 A 194 LEU SER GLY LYS LYS TYR SER VAL ASP ASP LEU HIS SER SEQRES 8 A 194 MSE GLY ALA GLY ASP LEU LEU ASN SER MSE PHE GLU PHE SEQRES 9 A 194 SER GLU LYS LEU ASN ALA LEU GLN LEU SER ASP GLU GLU SEQRES 10 A 194 MSE SER LEU PHE THR ALA VAL VAL LEU VAL SER ALA ASP SEQRES 11 A 194 ARG SER GLY ILE GLU ASN VAL ASN SER VAL GLU ALA LEU SEQRES 12 A 194 GLN GLU THR LEU ILE ARG ALA LEU ARG THR LEU ILE MSE SEQRES 13 A 194 LYS ASN HIS PRO ASN GLU ALA SER ILE PHE THR LYS LEU SEQRES 14 A 194 LEU LEU LYS LEU PRO ASP LEU ARG SER LEU ASN ASN MSE SEQRES 15 A 194 HIS SER GLU GLU LEU LEU ALA PHE LYS VAL HIS PRO SEQRES 1 B 194 MSE SER LYS SER PRO TYR VAL ASP PRO HIS LYS SER GLY SEQRES 2 B 194 HIS GLU ILE TRP GLU GLU PHE SER MSE SER PHE THR PRO SEQRES 3 B 194 ALA VAL LYS GLU VAL VAL GLU PHE ALA LYS ARG ILE PRO SEQRES 4 B 194 GLY PHE ARG ASP LEU SER GLN HIS ASP GLN VAL ASN LEU SEQRES 5 B 194 LEU LYS ALA GLY THR PHE GLU VAL LEU MSE VAL ARG PHE SEQRES 6 B 194 ALA SER LEU PHE ASP ALA LYS GLU ARG THR VAL THR PHE SEQRES 7 B 194 LEU SER GLY LYS LYS TYR SER VAL ASP ASP LEU HIS SER SEQRES 8 B 194 MSE GLY ALA GLY ASP LEU LEU ASN SER MSE PHE GLU PHE SEQRES 9 B 194 SER GLU LYS LEU ASN ALA LEU GLN LEU SER ASP GLU GLU SEQRES 10 B 194 MSE SER LEU PHE THR ALA VAL VAL LEU VAL SER ALA ASP SEQRES 11 B 194 ARG SER GLY ILE GLU ASN VAL ASN SER VAL GLU ALA LEU SEQRES 12 B 194 GLN GLU THR LEU ILE ARG ALA LEU ARG THR LEU ILE MSE SEQRES 13 B 194 LYS ASN HIS PRO ASN GLU ALA SER ILE PHE THR LYS LEU SEQRES 14 B 194 LEU LEU LYS LEU PRO ASP LEU ARG SER LEU ASN ASN MSE SEQRES 15 B 194 HIS SER GLU GLU LEU LEU ALA PHE LYS VAL HIS PRO MODRES 2V7C MSE A 407 MET SELENOMETHIONINE MODRES 2V7C MSE A 447 MET SELENOMETHIONINE MODRES 2V7C MSE A 486 MET SELENOMETHIONINE MODRES 2V7C MSE A 503 MET SELENOMETHIONINE MODRES 2V7C MSE A 541 MET SELENOMETHIONINE MODRES 2V7C MSE A 567 MET SELENOMETHIONINE MODRES 2V7C MSE B 407 MET SELENOMETHIONINE MODRES 2V7C MSE B 447 MET SELENOMETHIONINE MODRES 2V7C MSE B 477 MET SELENOMETHIONINE MODRES 2V7C MSE B 486 MET SELENOMETHIONINE MODRES 2V7C MSE B 503 MET SELENOMETHIONINE MODRES 2V7C MSE B 541 MET SELENOMETHIONINE MODRES 2V7C MSE B 567 MET SELENOMETHIONINE HET MSE A 407 8 HET MSE A 447 8 HET MSE A 486 8 HET MSE A 503 8 HET MSE A 541 8 HET MSE A 567 8 HET MSE B 407 8 HET MSE B 447 8 HET MSE B 477 8 HET MSE B 486 8 HET MSE B 503 8 HET MSE B 541 8 HET MSE B 567 8 HETNAM MSE SELENOMETHIONINE FORMUL 3 MSE 13(C5 H11 N O2 SE) FORMUL 4 HOH *59(H2 O1) HELIX 1 1 SER A 406 PHE A 409 5 4 HELIX 2 2 THR A 410 ARG A 422 1 13 HELIX 3 3 GLY A 425 LEU A 429 5 5 HELIX 4 4 SER A 430 LEU A 453 1 24 HELIX 5 5 ASN A 484 LEU A 496 1 13 HELIX 6 6 SER A 499 VAL A 512 1 14 HELIX 7 7 ASN A 521 HIS A 544 1 24 HELIX 8 8 ALA A 548 SER A 569 1 22 HELIX 9 9 GLU B 400 SER B 408 1 9 HELIX 10 10 PHE B 409 PRO B 411 5 3 HELIX 11 11 ALA B 412 ILE B 423 1 12 HELIX 12 12 GLY B 425 LEU B 429 5 5 HELIX 13 13 SER B 430 PHE B 450 1 21 HELIX 14 14 VAL B 471 MSE B 477 1 7 HELIX 15 15 GLY B 480 LEU B 496 1 17 HELIX 16 16 SER B 499 SER B 513 1 15 HELIX 17 17 ASP B 515 ILE B 519 5 5 HELIX 18 18 ASN B 521 HIS B 544 1 24 HELIX 19 19 ALA B 548 SER B 569 1 22 SHEET 1 AA 3 PHE A 454 ASP A 455 0 SHEET 2 AA 3 THR A 460 THR A 462 -1 O THR A 460 N ASP A 455 SHEET 3 AA 3 LYS A 468 TYR A 469 -1 O TYR A 469 N VAL A 461 SHEET 1 BA 3 PHE B 454 ASP B 455 0 SHEET 2 BA 3 THR B 460 THR B 462 -1 O THR B 460 N ASP B 455 SHEET 3 BA 3 LYS B 468 SER B 470 -1 O TYR B 469 N VAL B 461 LINK C SER A 406 N MSE A 407 1555 1555 1.33 LINK C MSE A 407 N SER A 408 1555 1555 1.33 LINK C LEU A 446 N MSE A 447 1555 1555 1.33 LINK C MSE A 447 N VAL A 448 1555 1555 1.33 LINK C SER A 485 N MSE A 486 1555 1555 1.33 LINK C MSE A 486 N PHE A 487 1555 1555 1.33 LINK C GLU A 502 N MSE A 503 1555 1555 1.33 LINK C MSE A 503 N SER A 504 1555 1555 1.33 LINK C ILE A 540 N MSE A 541 1555 1555 1.33 LINK C MSE A 541 N LYS A 542 1555 1555 1.33 LINK C ASN A 566 N MSE A 567 1555 1555 1.33 LINK C MSE A 567 N HIS A 568 1555 1555 1.33 LINK C SER B 406 N MSE B 407 1555 1555 1.32 LINK C MSE B 407 N SER B 408 1555 1555 1.33 LINK C LEU B 446 N MSE B 447 1555 1555 1.33 LINK C MSE B 447 N VAL B 448 1555 1555 1.33 LINK C SER B 476 N MSE B 477 1555 1555 1.33 LINK C MSE B 477 N GLY B 478 1555 1555 1.33 LINK C SER B 485 N MSE B 486 1555 1555 1.33 LINK C MSE B 486 N PHE B 487 1555 1555 1.33 LINK C GLU B 502 N MSE B 503 1555 1555 1.33 LINK C MSE B 503 N SER B 504 1555 1555 1.33 LINK C ILE B 540 N MSE B 541 1555 1555 1.33 LINK C MSE B 541 N LYS B 542 1555 1555 1.33 LINK C ASN B 566 N MSE B 567 1555 1555 1.33 LINK C MSE B 567 N HIS B 568 1555 1555 1.33 CRYST1 71.677 71.677 145.566 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013951 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013951 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006870 0.00000